amikacin has been researched along with Lung Diseases, Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, WM; Chu, XM; Dai, YJ; Ling, SS; Rui, JZ; Zhou, YG | 1 |
1 trial(s) available for amikacin and Lung Diseases, Obstructive
| Article | Year |
|---|---|
[The clinical manifestation and drug sensitive tests of lower respiratory tract infection by enterobacter cloacae. The Pulmonary Infection and Fibrosis Group, Thoracic Society Shanghai Medical Association].
Topics: Adult; Aged; Amikacin; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Humans; Imipenem; Lung Diseases, Obstructive; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Respiratory Tract Infections | 1997 |
1 other study(ies) available for amikacin and Lung Diseases, Obstructive
| Article | Year |
|---|---|
[Analysis of population pharmacokinetics with NONMEM in clinical patients treated with amikacin by intravenous infusion].
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Creatinine; Female; Humans; Infusions, Intravenous; Lung Diseases, Obstructive; Male; Middle Aged; Nonlinear Dynamics; Respiratory Tract Infections | 1996 |